Clinical Trial Update: PHL Treatment in Pancreatic Cancer [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 clinical trial evaluating PHL treatment for pancreatic ductal adenocarcinoma is currently recruiting at Fox Chase Cancer Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• PHL Treatment

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Pancreatic Ductal Adenocarcinoma | EARLY_Phase 1 | Status: RECRUITING